BioLineRx Receives Approval for Commencing Phase II Clinical Trial of BL-7040

News   Mar 06, 2012

 
BioLineRx Receives Approval for Commencing Phase II Clinical Trial of BL-7040
 
 
 

RELATED ARTICLES

‘Mini Tumors’ from Patient Samples Could Help Personalize Cancer Drug Treatment

News

Testing cancer drugs on miniature replicas of a patient’s tumour could help doctors tell in advance which treatments will work, a major new study reports.

READ MORE

Scientists Report The Development of a Potent New Medicine to Fight Addiction

News

Scientists report the development of a potent new medicine to fight addiction.

READ MORE

Minoryx Therapeutics spins off SEE-Tx platform into new company, Gain Therapeutics

News

The new Swiss company will operate in Lugano and Barcelona under the scientific management of Minoryx co-founder Dr Xavier Barril.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE